Quantcast

Posts related to ‘MRK’

Top Analyst Upgrades & Downgrades (AKAM, GAS, AAPL, ARMH, B, COST, XOM, FR, HTH, IART, IGT, MRK, P, PENN, PVH, RBS, SCCO, THOR)

Posted: January 9, 2012 at 8:09 am

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Monday morning. Akamai Technologies, Inc. (NASDAQ: AKAM) Cut to Sell ...
Read Full Story »

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

Posted: January 4, 2012 at 8:01 am

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like ...
Read Full Story »

DJIA 2012: Best Targets Imply DJIA 13,678 (BAC, JPM, VZ, IBM, CVX, MCD, CSCO, XOM, GE, HPQ, INTC, MRK, PFE, PG, WMT, DIA)

Posted: January 3, 2012 at 6:40 am

As each new year replaces the prior year, 24/7 Wall St. looks at the individual targets on all 30 Dow Jones Industrial Average price targets from Wall Street analysts to ...
Read Full Story »

Which Dogs of the Dow Are Best in 2012? (T, VZ, MRK, PFE, GE, DD, JNJ, INTC, PG, MSFT, CVX, JPM, KFT, MCD)

Posted: December 29, 2011 at 1:02 pm

The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones Industrial Average components, appears to be undergoing a bit of ...
Read Full Story »

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Posted: December 8, 2011 at 11:14 am

We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead.  Among those we expect to raise the ...
Read Full Story »

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

Posted: December 6, 2011 at 12:45 pm

Dendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment.  Unfortunately, PROVENGE sales ran slower than expected after the FDA took forever to ...
Read Full Story »

More DJIA Stocks Set to Hike Dividends Very Soon (DIS, DIA, T, VZ, CSCO, KO, IBM, JNJ, JPM, MMM, PFE, MRK, WMT, DVY, VIG, PFM, HDV)

Posted: December 2, 2011 at 6:31 am

Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company (NYSE: DIS) joined in on the dividend hike brigade with ...
Read Full Story »

Media Digest (11/23/2011) Reuters, WSJ, FT, Bloomberg

Posted: November 23, 2011 at 5:53 am

China’s factory activity reaches a 32-month low. (Reuters) Merck (NYSE: MRK) pays $950 million to settle Vioxx charges brought by the government. (Reuters) FCC head wants more examination of the ...
Read Full Story »

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

Posted: November 21, 2011 at 1:47 pm

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like ...
Read Full Story »

All 30 DJIA Dividend Trends into 2012, Stock by Stock (DIA, AA, AXP, T, BAC, BA, CAT, CVX, CSCO, KO, DD, XOM, GE, HD, HPQ, IBM, INTC, JNJ, JPM, KFT, MCD, MMM, MRK, MSFT, PFE, PG, TRV, UTX, VZ, WMT, DIS)

Posted: November 15, 2011 at 2:17 pm

The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain for companies to continue returning capital to shareholders while also ...
Read Full Story »

24/7 Closing Bell (AMD, FSLR, POT, PAAS, S, OXY, CVX, CSTR, MRK, BIDU, WY, IPG, SWC, ALGN, STMP, CPSI, CODE, DRIV)

Posted: October 28, 2011 at 4:04 pm

Markets opened slightly lower this morning and spent the morning trying to decide on a direction. The Reuters/University of Michigan Consumer Sentiment Index rose more than expected, but even ...
Read Full Story »

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Posted: October 25, 2011 at 6:24 am

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring ...
Read Full Story »

R&D Spenders Get No Respect

Posted: October 24, 2011 at 6:33 am

A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is the conclusion of a new study by Booz & Co., ...
Read Full Story »

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Posted: October 20, 2011 at 10:58 am

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will ...
Read Full Story »

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Posted: October 12, 2011 at 2:10 pm

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription ...
Read Full Story »